Julián Torre‐Cisneros

9.8k citations
141 papers · 4.7k indexed · 2 hit papers · h-index 33
Topics
Cytomegalovirus and herpesvirus research (39 papers)Antibiotic Resistance in Bacteria (32 papers)Herpesvirus Infections and Treatments (24 papers)
Partner nations
SpainUnited StatesItaly

In The Last Decade

Julián Torre‐Cisneros

135 papers receiving 4.6k citations

Hit Papers

Efficacy and safety o...200320262010201820202003100200300400500

Peers

Julián Torre‐Cisneros
Comparison fields: 5 of 108
  • Epidemiology 2.8k
  • Infectious Diseases 1.7k
  • Molecular Medicine 1.2k
  • Pharmacology 760
  • Applied Microbiology and Biotechnology 564
Replace Fernanda P. Silveira with:
Fernanda P. Silveira United States
Shirish Huprikar United States
Gopi Patel United States
M. E. Falagas United States
Satoshi Ichiyama Japan
Natividad Benito Spain
Michael J. Satlin United States
Carlos Cervera Spain
Francesco Menichetti Italy
Genovefa A. Papanicolaou United States
Julián Torre‐Cisneros relative to Fernanda P. Silveira United States Fernanda P. Silveira's profile →
Citations per field
00.5×1.7×
Fernanda P. Silveira · 1×
Citations per year

Countries citing papers authored by Julián Torre‐Cisneros

Since Specialization
Citations

This map shows the geographic impact of Julián Torre‐Cisneros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julián Torre‐Cisneros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julián Torre‐Cisneros more than expected).

Fields of papers citing papers by Julián Torre‐Cisneros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julián Torre‐Cisneros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julián Torre‐Cisneros. The network helps show where Julián Torre‐Cisneros may publish in the future.

Co-authorship network of co-authors of Julián Torre‐Cisneros

This figure shows the co-authorship network connecting the top 25 collaborators of Julián Torre‐Cisneros. A scholar is included among the top collaborators of Julián Torre‐Cisneros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julián Torre‐Cisneros. Julián Torre‐Cisneros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 9
4 5
5
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial
25
6 12
7 26
8 20
9 10
10 11
11 119
12 39
13 21
14 9
15 30
16 2
17 21
18 29
19 99
20 1

About Julián Torre‐Cisneros

Julián Torre‐Cisneros is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Epidemiology, having authored 141 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (39 papers), Antibiotic Resistance in Bacteria (32 papers) and Herpesvirus Infections and Treatments (24 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (564 citations), Molecular Medicine (1.2k citations) and Infectious Diseases (1.7k citations). Julián Torre‐Cisneros has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Antonio Rivero, José María Aguado, Juan José Castón, Richard N. Greenberg, B. Dupont, Irja Lutsar, Haran T. Schlamm, John R. Perfect, Jesús Rodríguez‐Baño and G. Just‐Nübling. Their work appears in journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026